U.S. Media Stock News

In early January 2025, Williams Companies completed a registered offering of US$500 million in 5.650% Senior Notes due 2033, US$1.25 billion in 5.150% Senior Notes due 2036, and US$1 billion in 5.950% Senior Notes due 2056, all senior unsecured obligations with semi‑annual interest payments and callable features. This large-scale refinancing, alongside progress on major natural gas pipeline projects such as Northeast Supply Enhancement, has sharpened investor focus on how Williams is...

Agnico Eagle Mines has recently reported that higher gold prices, tight cost control and technology-driven productivity gains have converted much of the price strength into profit growth across its primarily Canadian and Finnish operations. The company’s emphasis on low-cost production, automation and a pipeline of new projects in politically stable regions is increasingly central to how it seeks to expand output while managing risk. Now we will examine how Agnico Eagle’s ability to turn...

ResMed (RMD) is back on investor radars after recent data highlighted its revenue and earnings growth, improving free cash flow margins, and a share price sitting below its five year average P/S multiple. See our latest analysis for ResMed. The recent 1-day share price return of 1.90% and 7-day share price return of 4.55% suggest some short term momentum is building, even though the 90-day share price return of 3.89% points to a softer patch. At the same time, a 1-year total shareholder...

If you are wondering whether Pool at US$265.34 is offering fair value or a potential mispricing, this breakdown is designed to help you frame that question clearly. The share price has moved 12% over the last 7 days and 11.3% over the last 30 days, with a 15.5% return year to date, set against a 21.7% decline over 1 year and a 23.1% and 23.2% decline over 3 and 5 years. Recent coverage of Pool has focused on how investors are reassessing the stock after this combination of short term gains...

On January 6, 2026, a Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont, Chemours, 3M and others concealed PFAS risks in firefighter turnout gear, allowing RICO and multi-state claims tied to costly gear replacement and health concerns to proceed. The ruling highlights potential multi-billion dollar equipment replacement exposure for municipalities and firefighting organizations, and underscores judicial willingness to treat alleged PFAS concealment as a...

TransMedics Group, Inc. has recently signed a long-term lease for a 498,000-square-foot global headquarters at Assembly Innovation Park in Somerville, Massachusetts, and acquired adjacent land to build an integrated campus consolidating corporate, R&D, and advanced manufacturing operations, with relocation planned by January 2028. A key aspect of this expansion is the extensive public support, including up to US$18,000,000 in state job-linked tax incentives and up to US$18,000,000 in local...

Investor focus on Welltower (WELL) has sharpened as the company approaches its fourth quarter earnings release, with expectations for a double digit EPS increase and a record of exceeding Street profit forecasts. See our latest analysis for Welltower. At a share price of $188.71, Welltower has seen a 9.66% 90 day share price return and a 51.69% 1 year total shareholder return. This indicates that momentum is building as investors react to earnings optimism and reassess the company’s risk and...

In early January 2026, Primoris Services Corporation drew investor attention as it presented at the Goldman Sachs Energy, CleanTech & Utilities Conference in Florida and the CJS Securities “New Ideas for the New Year” Investor Conference, highlighting its infrastructure capabilities to a broad institutional audience. Shortly after these appearances, Guggenheim upgraded its rating on Primoris Services, signaling a shift in analyst sentiment that could influence how investors assess the...

Home Depot (HD) is drawing investor attention after a recent share price move, with the stock closing at US$375.95. That level comes alongside mixed short term returns over the past week, month, and past 3 months. See our latest analysis for Home Depot. That recent move to US$375.95 comes after an 8.71% year to date share price return. Meanwhile, the 1 year total shareholder return of a 5.11% decline and a 54.81% gain over five years suggest shorter term momentum is still catching up to the...

Earlier this month, Keysight Technologies highlighted two developments: a live 3GPP Release 19 NR‑NTN band n252 satellite-to-satellite connection with Samsung’s next‑generation modem at CES 2026, and the launch of its AI Software Integrity Builder to enhance testing and assurance of AI systems in safety‑critical settings such as automotive. Together, these advances underline Keysight’s push into emerging direct‑to‑cell satellite connectivity and regulatory‑aligned AI assurance, broadening...

Interactive Brokers Group (IBKR) recently attracted renewed attention after receiving a Zacks Rank #2 (Buy) upgrade, reflecting higher earnings estimates over the past 3 months and analysts indicating stronger underlying business trends. See our latest analysis for Interactive Brokers Group. The recent upgrade appears against a backdrop of firm share price momentum, with a 30 day share price return of 13.49% and a 1 year total shareholder return of 54.38%. This points to interest that extends...

AGNC Investment Corp. recently announced that its Board re-elected housing economist Dr. Morris Davis as an independent director effective January 12, 2026, and confirmed a US$0.12 per-share cash dividend for January 2026, payable on February 10, 2026 to stockholders of record on January 30, 2026. Dr. Davis’s return to the Board, following his tenure as Chief Housing Economist on the President’s Council of Economic Advisors, brings specialized housing and mortgage market expertise back into...

Earlier in January 2026, Monte Rosa Therapeutics completed a roughly US$300.00 million follow-on equity offering, including 11,125,000 common shares at US$24 each and 1,375,000 pre-funded warrants, shortly after releasing positive interim Phase 1 data for its NEK7-directed degrader MRT-8102 in inflammatory conditions. The Phase 1 results, showing deep NEK7 degradation alongside broad reductions in inflammatory markers such as hsCRP and IL-6 with a favorable safety profile in higher...

Concrete Pumping Holdings (BBCP) just wrapped up FY 2025 with fourth quarter revenue of US$108.8 million and basic EPS of US$0.10, alongside net income of US$4.9 million, setting the tone for how the year closed out. The company has seen quarterly revenue move from US$111.5 million and EPS of US$0.17 in Q4 FY 2024 to US$108.8 million and EPS of US$0.10 in Q4 FY 2025, while trailing twelve month net profit margins sit at 1.2% compared with 3.4% a year earlier, so investors are weighing modest...

NextEra Energy has previously announced that it will release its fourth-quarter and full-year 2025 financial results before the NYSE opens on January 27, 2026, followed by a webcast where senior management will review the numbers and outlook with investors. This scheduled earnings release, coming amid steady analyst optimism and the company’s positioning in clean power, is sharpening focus on how its fundamentals align with broader expectations for stable growth in the utility and renewables...

Nuvalent (NUVL) is back in focus after the FDA accepted its New Drug Application for zidesamtinib and set a PDUFA action date of September 18, 2026, which is anchoring expectations around its first potential commercial launch. See our latest analysis for Nuvalent. The NDA news has arrived after a strong run, with Nuvalent’s share price at US$107.84 and a 90 day share price return of 16.56%, while the 1 year total shareholder return of 41.91% and 3 year total shareholder return of around 3.3x...

VSE (VSEC) has drawn fresh attention after a strong recent share move, with the stock up about 23% over the past month and 34% over the past 3 months based on provided returns. See our latest analysis for VSE. At a latest share price of $208.83, VSE has seen a 23.29% 30 day share price return and a 33.61% 90 day share price return, while its 1 year total shareholder return of 108.67% and 5 year total shareholder return of about 4.4x indicate strong momentum rather than a short term swing in...

PACCAR (PCAR) is back in focus after recent trading left the shares around $119, prompting investors to reassess how its truck manufacturing, parts distribution, and financial services segments line up with current return and valuation metrics. See our latest analysis for PACCAR. While the 1 day share price return shows a small pullback, the 90 day share price return of 25.05% and 1 year total shareholder return of 11.39% suggest momentum has been building over both shorter and longer...

TechnipFMC: recent performance snapshot TechnipFMC (FTI) has drawn fresh attention after a strong stretch of share performance, with returns of 3.6% over the past day, 6.2% in the past week, and 13.1% over the past month. See our latest analysis for TechnipFMC. That near term strength builds on a much longer run, with the share price delivering a 46.3% 90 day share price return and a 1 year total shareholder return of 62.0%, suggesting momentum has been building rather than fading. If...

Recent attention on Medtronic (MDT) has centered on two fresh catalysts: a partnership with Precision Neuroscience to link brain activity data with surgical navigation tools, and FDA 510(k) clearance for its connected MiniMed Go diabetes system. See our latest analysis for Medtronic. Those neurosurgery and diabetes updates come as Medtronic’s share price sits at US$98.74, with a 3.9% 90 day share price return and a 19.3% 1 year total shareholder return. This suggests momentum has been...

Wave Life Sciences recently outlined its 2026 priorities at the 44th Annual J.P. Morgan Healthcare Conference, emphasizing accelerated development of obesity candidate WVE-007, expansion of its RNA editing pipeline, and upcoming trials and regulatory filings across obesity, liver disease, and genetic disorders. A key highlight for investors was early WVE-007 data suggesting fat loss on par with GLP-1 therapies while preserving muscle, alongside planned multidose and add-on incretin trials...

Lindsay (LNN) shares have been reacting to the company’s first quarter earnings, which showed sales of US$155.82 million and net income of US$16.52 million, both below the comparable period last year. See our latest analysis for Lindsay. The recent first quarter results, along with a reaffirmed quarterly dividend and a new Chief Accounting Officer, come as Lindsay’s share price sits at US$124.72. The 7 day share price return is 5.21%, while the 1 year total shareholder return shows a 3.43%...

Understanding what is moving SiriusPoint shares SiriusPoint (SPNT) has stayed on investors’ radars after mixed recent returns, with a gain over the past 3 months but declines over the past month and year to date prompting closer attention. See our latest analysis for SiriusPoint. The latest share price of $20.17 sits alongside a 30 day share price return of a 9.63% decline and a 90 day share price return of a 13.63% gain. The 1 year total shareholder return of 36.38% and 3 year total...

Dillard's stock performance snapshot Dillard's (DDS) has drawn investor interest after a mixed return profile, with a 1 day decline of 7.4% and a month pullback of 4.4%, alongside a 1 year total return of 49.7%. See our latest analysis for Dillard's. The recent 7.4% one day share price decline and softer 1 month share price return sit against a much stronger backdrop, with the 1 year total shareholder return close to 50% and the 5 year total shareholder return above 10x. If Dillard's recent...